This is an auto-generated stub page built from atlas entry frontmatter. A richer
hand-crafted page is planned. See the
atlas source
for the full entry including detailed body sections.
iga-nephropathy
IgA Nephropathy
IgA nephropathy is the most common primary glomerulonephritis globally; galactose-deficient IgA1 (Gd-IgA1) → mesangial immune complex deposition → complement + CCL2 → macrophage infiltration → fibrosis; sparsentan, iptacopan, and budesonide (Tarpeyo) are recently approved.
Entry Metadata
| Field | Value |
|---|---|
| ID | iga-nephropathy |
| Name | IgA Nephropathy |
| Status | draft |
| Last reviewed | 2026-06-07 |
| Atlas | 01-human |
| Scale | 07-system |
Cross-Atlas Connections
Sources
- Barratt J, Feehally J. IgA nephropathy. J Am Soc Nephrol. 2005;16(7):2088-2097. · PubMed 15987751
- Heerspink HJL, Radhakrishnan J, Alpers CE, et al. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial. Lancet. 2023;401(10388):1584-1594. · PubMed 37062299